Table 2.
Frequencies of RP-ILD among patients with different MSAs.
| MSAs | Cases | RP-ILD | Chronic ILD | P value* |
|---|---|---|---|---|
| Total | 333 | 180(54.1) | 153(45.9) | |
| Anti-MDA5 | 175 | 110(62.9) | 65(37.1) | 0.001 |
| Anti-ARS | 158 | 70(44.3) | 88(55.7) | 0.001 |
| Jo-1 | 79 | 34(43.0) | 45(57.0) | 0.024 |
| PL-7 | 35 | 19(54.3) | 16(45.7) | 0.977 |
| PL-12 | 17 | 6(35.3) | 11(64.7) | 0.111 |
| EJ | 27 | 11(40.7) | 16(59.3) | 0.148 |
MSAs, myositis specific autoantibodies. *indicated that the results were certain MSA positive group comparison with negative group.